Cord Blood Stem Cell TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningHematologic NeoplasmsCytomegalovirus InfectionsRoseolovirus InfectionsAspergillosisHistocompatibility TestingStem CellsCytomegalovirusTreatment OutcomeFetal BloodBone Marrow TransplantationTransplantation, AutologousTissue DonorsRetrospective StudiesTransplantation ChimeraGraft SurvivalHematopoietic Stem CellsPeripheral Blood Stem Cell TransplantationImmunosuppressive AgentsGraft vs Leukemia EffectRecurrenceBusulfanTransplantationImmunocompromised HostLeukemiaKidney TransplantationMyeloablative AgonistsHistocompatibilityVidarabineGraft vs Tumor EffectRemission InductionGraft RejectionTime FactorsWhole-Body IrradiationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteOpportunistic InfectionsTransplantsLymphocyte DepletionSpinal CordEmbryonic Stem CellsT-LymphocytesMycosesPrecursor Cell Lymphoblastic Leukemia-LymphomaSurvival AnalysisMultiple MyelomaVirus ActivationAntigens, CD34SiblingsSalvage TherapySurvival RateAdult Stem CellsHematopoietic Stem Cell MobilizationCombined Modality TherapyAnemia, AplasticImmunosuppressionAcute DiseaseChimerismMyelodysplastic SyndromesHepatic Veno-Occlusive DiseaseHematologic DiseasesMinor Histocompatibility AntigensAntilymphocyte SerumGanciclovirCyclosporineHerpesvirus 6, HumanHLA AntigensCell DifferentiationLymphocyte TransfusionTransplantation ImmunologyPluripotent Stem CellsFollow-Up StudiesLeukocyte TransfusionFatal OutcomeAntiviral AgentsLymphoproliferative DisordersFlow CytometryDisease-Free SurvivalCells, CulturedSpinal Cord InjuriesNeoplasm, ResidualHeart TransplantationAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideRisk FactorsPyrimidinesBone Marrow CellsStem Cell NichePrognosisAntifungal AgentsProspective StudiesNeural Stem CellsInduced Pluripotent Stem CellsMesenchymal Stem Cell TransplantationMelphalan